ALDH2 and melanoma: In addition, the expression of ALDH2 has been found to be a potential prognostic indicator for a number of malignancies; e.g., the downregulation of ALDH2 expression was associated with poorer prognosis in hepatocellular carcinoma [53], melanoma [54], and lung adenocarcinoma [55].